Cargando…
Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are an attractive novel therapeutic option for the treatment of type 2 diabetes. They block the reabsorption of filtered glucose in kidneys, mainly in proximal renal tubules, resulting in increased urinary glucose excretion and correction of the dia...
Autores principales: | Gomez-Peralta, Fernando, Abreu, Cristina, Lecube, Albert, Bellido, Diego, Soto, Alfonso, Morales, Cristóbal, Brito-Sanfiel, Miguel, Umpierrez, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630545/ https://www.ncbi.nlm.nih.gov/pubmed/28721687 http://dx.doi.org/10.1007/s13300-017-0277-0 |
Ejemplares similares
-
Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes
por: Gomez-Peralta, Fernando, et al.
Publicado: (2017) -
SGLT2-Inhibitoren: Was gibt es Neues?
por: Dumann, Eva, et al.
Publicado: (2021) -
Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting
por: Chadha, Manoj, et al.
Publicado: (2022) -
Practical Guidance for Healthcare Providers on Collaborating with People with Type 2 Diabetes: Advancing Treatment and Initiating Injectable Therapy
por: Boeder, Schafer, et al.
Publicado: (2022) -
Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis
por: Gualtierotti, Roberta, et al.
Publicado: (2017)